|
C9ORF40 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.482100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.303700E-02 |
| Normal-vs-Stage2 |
9.002800E-01 |
| Normal-vs-Stage3 |
5.284200E-03 |
| Normal-vs-Stage4 |
4.808000E-01 |
| Stage1-vs-Stage2 |
2.919200E-01 |
| Stage1-vs-Stage3 |
8.284300E-02 |
| Stage1-vs-Stage4 |
6.678200E-01 |
| Stage2-vs-Stage3 |
8.221600E-02 |
| Stage2-vs-Stage4 |
6.451800E-01 |
| Stage3-vs-Stage4 |
2.450800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.026400E-02 |
| Normal-vs-AfricanAmerican |
2.928000E-01 |
| Normal-vs-Asian |
1.681840E-01 |
| Caucasian-vs-AfricanAmerican |
5.896000E-01 |
| Caucasian-vs-Asian |
5.142000E-01 |
| AfricanAmerican-vs-Asian |
3.075200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.744200E-02 |
| Normal-vs-Female |
1.899190E-01 |
| Male-vs-Female |
3.613400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.310400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.245590E-01 |
| Normal-vs-Age(61-80Yrs) |
5.890200E-02 |
| Normal-vs-Age(81-100Yrs) |
2.724300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.499000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.897800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.383640E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.856400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.134420E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.072200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.796400E-02 |
| Normal-vs-Grade 2 |
1.376980E-01 |
| Normal-vs-Grade 3 |
1.220470E-03 |
| Normal-vs-Grade 4 |
5.503200E-01 |
| Grade 1-vs-Grade 2 |
6.246100E-02 |
| Grade 1-vs-Grade 3 |
1.628470E-02 |
| Grade 1-vs-Grade 4 |
2.045800E-01 |
| Grade 2-vs-Grade 3 |
1.602320E-03 |
| Grade 2-vs-Grade 4 |
8.537400E-01 |
| Grade 3-vs-Grade 4 |
1.959360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.224400E-01 |
| Normal-vs-ccB subtype |
3.073900E-02 |
| ccA subtype-vs-ccB subtype |
5.719900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.366040E-01 |
| Normal-vs-N1 |
3.989800E-02 |
| N0-vs-N1 |
8.200200E-02 |
|
|
